Venetoclax + cytarabine
Venetoclax + cytarabine is a combination of medicines that can be used to treat some people with acute myeloid leukaemia (AML).
Summary
- Venetoclax + cytarabine is used to treat some adults with acute myeloid leukaemia (AML).
- Venetoclax is a targeted medicine. It comes as film-coated tablets that you take by mouth.
- Cytarabine is a type of chemotherapy medicine. You have it as an injection just under your skin.
- You will have regular blood tests to check how well the treatment is working and how your body is coping with it.
- You may get some side effects while you are having venetoclax + cytarabine. Some people have very few side effects, whereas other people experience more serious side effects.
- Some side effects can be serious if not treated promptly. Contact your haematology team straight away if:
- You have a high temperature (over 38°C), feel shivery or generally unwell.
- You have a cough, chest pain or wheezing with a high temperature, feeling tired, an aching body and loss of appetite.
- You are feeling confused, slurring your words or not making sense.
- You have blue, grey, pale or blotchy skin, lips or tongue. This may look different on black or brown skin.
- You have a rash that doesn’t fade when you roll a glass over it.
- You have difficulty breathing, shortness of breath or breathing very fast.
About venetoclax + cytarabine
Your haematology team might recommend venetoclax + cytarabine for you if:
- You have been newly diagnosed with AML AND
- Intensive chemotherapy is not suitable for you
Sometimes venetoclax may be given with other medicines instead of cytarabine. Your medical team will let you know which combination of medicines you are taking.
We have separate information about venetoclax for CLL or combined with other medicines.
Ventoclax
Venetoclax is a targeted medicine that blocks a protein called BCL-2. This protein is present in some cancer cells. Blocking it can help kill cancer cells.
The brand name for venetoclax is Venclyxto.
Cytarabine
Cytarabine is a chemotherapy medicine that stops your cancer cells from making and repairing DNA. This can stop cancer cells from growing and dividing.
There is no brand name for cytarabine. You might hear some people call it Ara-C.
Before having this treatment
Before starting venetoclax + cytarabine, your haematology team will carry out checks to make sure it is suitable for you. These might include:
- Blood tests to measure your blood counts
- If your white blood cell count is too high, you might have treatment to lower it before starting venetoclax + cytarabine
- Blood tests to check your liver and kidney function, and the levels of salts in your body
- Bone marrow test
Things to tell your haematology team
Before starting treatment, you should let your haematology team know if you:
- Have kidney disease, liver disease or any problems with your liver
- Have recently had cancer treatment, radiotherapy or are due to have radiotherapy
- Have an infection, or have had a long-lasting or repeated infection
Some medicines or drugs may interact with venetoclax. It is important to tell your haematology team about any medicines or supplements you are taking. This includes prescribed medicines and medicines you have bought yourself without a prescription. Examples include:
- Herbal medicines, such as St John’s Wort
- Some antibiotic, antifungal and antiviral medicines
- Some medicines used to treat high blood pressure (including high blood pressure in your lungs)
- Modafinil, a medicine used to treat sleeping disorders
- Digoxin, a medicine used to treat heart failure or abnormal heart rhythms
- Dabigatran, a medicine used to treat and prevent blood clots and stroke
Studies in animals found that venetoclax might cause a low or no sperm count. Scientists do not know if this is the same for humans. If you were born male and you may want to have children in the future, ask your haematology team for advice on sperm storage before starting treatment.
Having venetoclax + cytarabine
You will receive treatment in a cycle of 28 days. This is made up of some days where you will have venetoclax + cytarabine, and some days where you only have venetoclax.
Having venetoclax
Venetoclax comes as film-coated tablets containing 10mg, 50mg or 100mg of venetoclax. The number of tablets that you take depends on the dose and strength of the tablets. Your dose should be printed on the named label on the medicine packaging. If you are not sure, ask your doctor or nurse.
- You should take venetoclax as prescribed so it can work as well as possible. Try and take it with food at the same time of day if you can.
- Swallow the venetoclax tablets whole with a full glass of water. To make sure you get the right dose, do not break, crush, dissolve or chew the tablet.
- Your doctor will give you tablets to control your uric acid levels. You usually need to take these during the first 4 days of treatment while your venetoclax dose is being increased.
- Drink plenty of water, especially during the first few days of treatment. This reduces the risk of getting side effects from the breakdown of cancer cells.
- If you are sick after taking a tablet, do not take another dose on the same day. Instead, wait until the next day and take your dose as normal. It is important not to take a double dose.
- If you forget to take your venetoclax tablet:
- And it is less than 8 hours since the time you usually take your dose, take it as soon as possible.
- And it is more than 8 hours since the time you usually take your dose, do not take a dose that day. Take your normal dose at the normal time the next day.
Having cytarabine
You usually have cytarabine as an injection under your skin.
- You have cytarabine in treatment cycles. Each cycle lasts 28 days.
- You have a cytarabine injection once a day for 10 days, followed by 18 days when you do not have an injection.
- Your doctor or nurse will give you cytarabine at the hospital, usually on a day unit, and you can go home the same day. Or it may be possible to give yourself the injections at home with training from your specialist team.
Dose
Your haematology team will let you know what dose you are on, but below are the most common doses that are used.
Venetoclax
You start on a low dose of venetoclax. Your doctor usually increases the dose every day for 4 days until you reach the full dose. Most people have:
- Day 1: 100mg once a day
- Day 2: 200mg once a day
- Day 3: 400mg once a day
- Day 4 onwards: 600mg once a day
Cytarabine
Your doctor will work out the best dose of cytarabine for you based on your height, weight and how well you respond to treatment. They will tell you what dose they recommend for you.
Precautions
There are several precautions to be aware of when you are having venetoclax + cytarabine.
- Do not eat, drink or use supplements that contain grapefruit, Seville oranges (usually used in marmalade) or starfruit. This is because they can increase the amount of venetoclax in your blood.
- Tell your haematology team if you are due to have any vaccines. You should not have live vaccines when you are being treated with venetoclax + cytarabine. It is OK to have non-live vaccines, but they might not work as well as usual.
Pregnancy, breastfeeding and fertility
Venetoclax + cytarabine may harm unborn babies.
- If you could get pregnant, it is important to use effective contraception. You need to do this while you are having venetoclax + cytarabine and for 6 months after you stop. The treatment might affect hormonal contraceptive pills or devices. So it is important to use a barrier method like a condom, diaphragm or cap.
- If you could make someone pregnant, it is important to use effective contraception. You need to do this while you are having venetoclax + cytarabine and for at least 3 months after you stop.
- If you think you might be pregnant, tell your haematology team as soon as possible. They may recommend stopping venetoclax + cytarabine for a while. They could also recommend switching to a different treatment.
- If you are planning to get pregnant, or make someone pregnant, tell your haematology team. They can discuss your treatment options with you.
Breastfeeding
Scientists are not sure if venetoclax + cytarabine passes into breast milk. If it does, it could be a risk for breastfed babies or children. You should not breastfeed when having venetoclax + cytarabine.
Monitoring
During your treatment with venetoclax + cytarabine you will have blood tests:
- Before you start treatment
- After each new dose of venetoclax when your dose is being gradually increased
- After reaching your full dose of venetoclax
- Regularly throughout your treatment with cytarabine
You may also have further blood and bone marrow tests during your treatment. Your haematology team will let you know what tests you need and how often.
Your haematology team will use the results of these tests to:
- Check how well venetoclax + cytarabine is working for you
- Make sure your blood counts have not dropped too low
- Check how well your liver and kidneys are working
- Check the level of salts in your blood
Tumour lysis syndrome
Chemotherapy kills cancer cells. When lots of cancer cells breakdown quickly, they can release a large amount of chemicals into your blood. This is known as tumour lysis syndrome. It can affect how well your kidneys work, as well as causing changes to your heartbeat and sometimes fits (seizures).
If you have a very high leukaemia cell count before treatment, your haematology team might give you medicine to help prevent tumour lysis syndrome. They will monitor you closely so they can treat it quickly if it happens.
How long to have this treatment
You usually carry on having venetoclax + cytarabine unless:
- It has not worked well enough
- It stops working well
- You are having side effects that are difficult to cope with
If this happens, your haematology team might stop venetoclax + cytarabine, adjust your dose or recommend a different treatment.
Do not stop taking venetoclax + cytarabine without talking to your haematology team.
Side effects
You may get some side effects while you are having venetoclax + cytarabine. Some people may have very few side effects, whereas other people experience more serious side effects.
Tell your haematology team about any side effects you have. They may be able to suggest things you can do or give you medicines to help.
If you are getting side effects that are difficult to cope with, your haematology team might suggest:
- Temporarily stopping treatment
- Lowering your dose of venetoclax + cytarabine
Serious side effects
The following side effects may be serious and require urgent treatment. Contact your doctor or nurse straight away if you have any of these side effects.
The most common serious side effects for people having venetoclax + cytarabine include:
- A high temperature (higher than 38°C) with a low white blood cell count (febrile neutropenia). You might also feel shivery or generally unwell.
- Pneumonia (a lung infection). You may get symptoms like:
- A cough, chest pain, shortness of breath, wheezing.
- A high temperature.
- An aching body, feeling very tired, loss of appetite.
- Sepsis, which is a life-threatening reaction to an infection. You may get symptoms like:
- Feeling confused, slurring your words, not making sense.
- Blue, grey, pale or blotchy skin, lips or tongue. This may look different on black or brown skin.
- A rash that doesn’t fade when you roll a glass over it.
- Difficulty breathing, shortness of breath or breathing very fast.
Venetoclax + cytarabine can lower your blood cell counts. This can mean you may be more likely to get infections, fever, bruising, bleeding, shortness of breath or feeling very tired. If you get any of these symptoms, tell your doctor or nurse straight away.
Very common side effects
Very common side effects affect more than 10 in every 100 people who are having venetoclax + cytarabine. Very common side effects include:
- A low platelet count, which might lead to unexpected bruising or bleeding like nosebleeds, bleeding gums, blood spots or rashes
- A low white blood cell count, which might mean that you get infections more often and any infections you get might last longer than usual
- A low red blood cell count (anaemia), which can make you feel tired, dizzy or short of breath
- Low potassium levels which can cause muscle weakness, muscle cramps and a fast and irregular heartbeat
- Swelling, due to a build up of fluid, in your legs, ankles and feet and sometimes your arms and hands
- Feeling sick or being sick
- Diarrhoea
- Constipation
Cytarabine syndrome
This is a type of allergic reaction that might happen 6 to 12 hours after having a cytarabine injection. You may get symptoms like:
- Fever
- Muscle aches and pains
- Bone pain
- Chest pain
- Reddish skin covered in bumps (this may look different on black or brown skin)
- Red and sore eyes
- Feeling sick
- Feeling generally unwell
If you experience these symptoms, tell your haematology team. They may give you steroids, if you need them.
If this treatment does not work
If venetoclax + cytarabine are not working well, your haematology team might suggest altering your treatment cycle, your dose, or stopping treatment if your blood counts drop.
If this is not suitable for you, or does not work, they will talk to you about your treatment options.
Sources we used to develop this information
AbbVie. Venclyxto 10 mg film-coated tablets – Patient Information Leaflet [Internet]. 2024. Available from https://www.medicines.org.uk/emc/product/2267/pil [Accessed Aug 2024].
AbbVie. Venclyxto 10 mg film-coated tablets – Summary of Product Characteristics [Internet]. 2024. Available from https://www.medicines.org.uk/emc/product/2267/smpc [Accessed Aug 2024].
AbbVie. Venclyxto 100 mg film-coated tablets – Patient Information Leaflet [Internet]. https://www.medicines.org.uk/emc/product/10476/pil [Accessed Aug 2024].
AbbVie. Venclyxto 100 mg film-coated tablets – Summary of Product Characteristics [Internet]. 2024. Available from https://www.medicines.org.uk/emc/product/10476/smpc [Accessed Aug 2024].
AbbVie. Venclyxto 50 mg film-coated tablets – Patient Information Leaflet [Internet]. 2024. Available from https://www.medicines.org.uk/emc/product/10475/pil [Accessed Aug 2024].
AbbVie. Venclyxto 50 mg film-coated tablets – Summary of Product Characteristics [Internet]. 2024. Available from https://www.medicines.org.uk/emc/product/10475/smpc [Accessed Aug 2024].
Hospira UK. Cytarabine Injection Solution 100 mg/ml – Patient Information Leaflet [Internet]. 2024. Available from https://www.medicines.org.uk/emc/product/1570/pil [Accessed Aug 2024].
Hospira UK. Cytarabine Injection Solution 100 mg/ml – Summary of Product Characteristics [Internet]. 2024. Available from https://www.medicines.org.uk/emc/product/1570/smpc [Accessed Aug 2024].
Hospira UK. Cytarabine Injection Solution 20 mg/ml – Patient Information Leaflet [Internet]. 2024. Available from https://www.medicines.org.uk/emc/product/1571/pil [Accessed Aug 2024].
Hospira UK. Cytarabine Injection Solution 20 mg/ml – Summary of Product Characteristics [Internet]. 2024. Available from https://www.medicines.org.uk/emc/product/1571/smpc [Accessed Aug 2024].
Wei AH, Montesinos P, Ivanov V, DiNardo CD, Novak J, Laribi K, Kim I, Stevens DA, Fiedler W, Pagoni M, Samoilova O. Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial. Blood, The Journal of the American Society of Hematology. 2020 Jun 11;135(24):2137-45.
Need support?
You are not alone. We're here for you whether you have a diagnosis yourself or know someone who has. If you'd like advice, support, or a listening ear, call our freephone helpline on 08088 010 444 or send a WhatsApp message to 07500 068 065.
Help us improve our information
We aim to provide information that’s reliable, up-to-date, and covers what matters to you. Please complete our short survey to help us improve our information and make sure it meets your needs.
About our information
This information is aimed at people in the UK. We do our best to make sure it is accurate and up to date but it should not replace advice from your health professional. Find out more about our information.
Page last reviewed: 31 January 2025
Updated February 2026
Next review due: 31 January 2028
More information
Just diagnosed with leukaemia
It can be hard to know where to start and what to do after a …
Acute myeloid leukaemia (AML)
Acute myeloid leukaemia (AML) is a fast-growing blood cancer. It develops when white blood cells …
Support and community
Leukaemia Care support people affected by leukaemia, myelodysplastic syndromes and myeloproliferative neoplasms. Find out about …
Need help understanding this information?
Our support team is here to answer your questions and provide guidance.
Contact Support